A 3-Month Non-Interventional Study of Asthmatics Treatment With Symbicort® Turbuhaler®
Symb NIS
1 other identifier
observational
310
1 country
19
Brief Summary
The purpose of this study is to investigate real practices of treatment with Symbicort Turbuhaler for 3 months in asthma and patient compliance.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Apr 2007
Shorter than P25 for all trials
19 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2007
CompletedFirst Submitted
Initial submission to the registry
September 20, 2007
CompletedFirst Posted
Study publicly available on registry
September 21, 2007
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2007
CompletedJune 9, 2009
June 1, 2009
September 20, 2007
June 8, 2009
Conditions
Study Arms (1)
1
Chinese asthma patient prescribed Symbicort® Turbuhaler®
Eligibility Criteria
Natural History, longitudinal, defined population
You may qualify if:
- Provision of informed consent
- Asthmatics who has been prescribed Symbicort according to physician's judgement
- Usage of Symbicort should follow local prescribing information
You may not qualify if:
- Not being involved in the planning and conduct of the study (applies to both AstraZeneca staff or staff at the study site)
- No previous enrolment in the present study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- AstraZenecalead
Study Sites (19)
Research Site
Hefel, Anhui, China
Research Site
Fuzhou, Fujian, China
Research Site
Guangzhou, Guangdong, China
Research Site
Shenzhen, Guangdong, China
Research Site
Zhengzhou, Henan, China
Research Site
Wuhan, Hubei, China
Research Site
Wuhan, Hubel, China
Research Site
Nanjong, Jiangsu, China
Research Site
Suzhou, Jiangsu, China
Research Site
Shenyand, Liaoning, China
Research Site
Qingdao, Shandong, China
Research Site
Taiyuan, Shanxi, China
Research Site
Xi’an, Shanxi, China
Research Site
Chengdu, Sichuan, China
Research Site
Wenzhou, Zhejiang, China
Research Site
Beijing, China
Research Site
Chongqing, China
Research Site
Hangzhou, China
Research Site
Shanghai, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Zhou Xin
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
- PRINCIPAL INVESTIGATOR
Hong Jianguo
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- INDUSTRY
Study Record Dates
First Submitted
September 20, 2007
First Posted
September 21, 2007
Study Start
April 1, 2007
Study Completion
November 1, 2007
Last Updated
June 9, 2009
Record last verified: 2009-06